<DOC>
	<DOCNO>NCT00383396</DOCNO>
	<brief_summary>To Determine topical cyclosporine 0.05 % BID prevent recurrent inflammation improve comfort eye pterygium .</brief_summary>
	<brief_title>Efficacy Topical Cyclosporine 0.05 % Prevention Ocular Surface Inflammation Secondary Pterygia</brief_title>
	<detailed_description />
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>pt symptomatic pterygium unresponsive palliative treatment .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>